Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Disposable Syringe Market Size to Reach USD 21.65 Billion in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

22 Dec, 2022, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Dec. 22, 2022 /PRNewswire/ -- The disposable syringe market size reached USD 13.07 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research. Rapid technological advancements in auto-injector syringes, increasing rate of immunization, substantial improvements in syringe manufacturing processes, as well as growing consumer demand from the pharmaceutical industry as well as growing market demand for safety syringes for surgeries are some key factors driving disposable syringe market revenue growth. Disposable syringes made of plastic are used in veterinary and medical research.

Traditional glass syringes are quickly being replaced with disposable ones because they are more frequently available, ready to use, and less expensive. Easily disposable needles are swiftly replacing the long-established glass needles because they are readily available in sterile conditions, ready for use, and cost-competitive. This is advantageous since it results in less waste when more expensive biotech drugs are introduced, especially if some vaccines are hard to come by or very expensive. As a result, disposable prefilled syringes are more in demand than conventional glass vials for the packaging of prescription pharmaceuticals in the medical sector, which is boosting the growth of this market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1200

Drivers:

Demand for disposable syringe devices has significantly increased over the years due to market demand for safety syringes for surgeries as well as growing consumer demand from pharmaceutical industry. Modern medicine frequently uses disposable syringes to collect blood, inject medications, and provide immunizations. In an effort to stop the spread of disease, they are frequently used in place of reusable syringes. The administration of local anesthetic by a dentist and the injection of insulin by a diabetic are two frequent applications of disposable syringes.

Disposable syringes are replacing glass syringes due to advantages including crack resistance and protection against damage in transit, as well as because they are readily available in sterilized condition, are economically viable, and are ready for use. The future growth possibilities, consumption patterns, and general outlook for this commodity are all quite favorable, in keeping with the booming pharmaceutical industry and the industry's growing emphasis on highly sterile environments and procedures. This has raised the demand for disposable prefilled syringes for packing prescription drugs in the pharmaceutical industry.

Restraints:

There are some issues and difficulties facing the disposable syringe industry. Despite major investments in the manufacturing of such syringes, the management of increased medical waste is becoming difficult due to increasing waste volume as well as improper disposal processes of disposable syringes and low adoption among patients with fear of syringes are a few factors hindering market revenue growth. Disposal of needles, syringes, lancets, and other medical products is not well controlled in the home and other industries. As a result, regularly discarding home-generated medical waste in the curbside garbage puts sanitation workers and cleaning staff in danger of suffering a needlestick wound, which is hindering the growth of disposable syringe market.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/disposable-syringes-market

Growth Projections:

The disposable syringe market is expected to register a CAGR of 5.8% over the forecast period and revenue is projected to increase from USD 13.07 Billion in 2021 to USD 21.65 Billion in 2030. Increasing spending in emerging markets is expected to support revenue growth of the market.

Current Trends and Innovations:

The disposable syringe industry is undergoing gradual change as a result of rapid technological advancements in auto injector syringes as well as growing market demand for safety syringes for surgeries. To date, almost 80 autoinjectors have been produced by more than 20 pharmaceutical companies. Approximately 50 medicines are being developed as combination products for use with autoinjectors. Disposable autoinjectors make up 62% of this. Reusable autoinjectors with various doses are being developed at a remarkable rate.

The necessity of user-friendly gadgets for both emergency use and chronic medical conditions has been highlighted by highly competent advances in the device manufacturing industry. Currently, there are close to 1.3 billion disposable pens with insulin cartridges. Pen devices are quite convenient because of features like a big display, dose adjustment, a geared or spring-driven injection mechanism, and easy cartridge replacement for reusable pens.

Autoinjector syringes have grown in popularity as a practical way to dispense medication due to an easy-to-use activation mechanism designed specifically for patients whose lack of dexterity makes it difficult for them to take medication using a standard syringe, and most autoinjectors are one-use, disposable, spring-loaded syringes. Patients and caregivers are becoming more active in selecting the best treatment option for disposable autoinjector syringes, which is driving this market's revenue growth.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1200

Strategic Initiatives:

Major companies included in the market report are Braun Medical, Inc., Novo Nordisk, Baxter International, Inc., Fresenius Kabi AG, Becton, Dickinson and Company, Terumo Corporation, Flextronics International Vita Needle Company, UltiMed, Inc., Henke-Sass, and Covidien.

  • On 2 December 2020, BD (Becton, Dickinson, and Company), a leading worldwide medical technology company, announced an investment of USD 1.2 billion over four years to strengthen and expand manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations, as well as add a new manufacturing facility in Europe.

Scope of Research

Report Details

Outcome

Market Size in 2021

USD 13.07 Billion

CAGR (2022–2030)

5.8 %

Revenue Forecast to 2030

USD 21.65 Billion

Base Year for Estimation

2021

Historical Data

2019–2020

Forecast Period

2022–2030

Quantitative Units

Revenue in USD Billion and CAGR in % from 2022 to 2030

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

type, application, end-use and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

Braun Medical, Inc., Novo Nordisk, Baxter International, Inc., Fresenius Kabi AG, Becton, Dickinson and Company, Terumo Corporation, Flextronics International Vita Needle Company, UltiMed, Inc., Henke-Sass, and Covidien.

Customization Scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1200

Emergen Research has segmented disposable syringe market on the basis of type, application, end-use, and region:

  • Type Outlook (Revenue, USD Billion; 2019-2030)
    • Conventional Syringes
    • Safety Syringes
    • Retractable Safety Syringes
    • Non-retractable Safety Syringes
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Immunization Injections
    • Therapeutic Injections
  • End-Use Outlook (Revenue, USD Billion; 2019-2030)
    • Hospitals
    • Diagnostic Laboratories
    • Blood Banks
    • Pharmaceutical Industry

Latest Research Reports Published by Emergen Research:

Therapeutic Ultrasound Market By Technology (High Intensity Focused Ultrasound and Extracorporeal Shockwave Lithotripsy), By End-Use (Hospitals, Clinics and Diagnostic Centers), By Application, and By Region Forecast to 2030

Radio Frequency Generator Market By Type (Free Running RF Signal Generators and Synthesized RF Signal Generators), By End-Use (Telecommunications, Aerospace & Defense, and Electronics), and By Region Forecast to 2030

Multichannel Order Management Market By Component (Software and Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises), By Deployment Mode (On-premises and Cloud), and By Region Forecast to 2030

Nitrile Gloves Market, By Type (Powder Free and Powdered), By Product (Durable and Disposable), By Grade (Medical Grade and Industrial Grade), By End-Use (Healthcare, Food & Beverage, and Chemical), and By Region Forecast to 2030

Data Center Accelerator Market, By Processor Type (Graphics Processing Unit (GPU) and Field Programmable Gate Array (FPGA)), By Type (Cloud Data Center), By Application (Deep Learning Training), and By Region Forecast to 2030

Glycomics and Glycobiology Market, By Product (Kits, Instruments, Enzymes, and Reagents), By Application (Diagnostics, Drug Discovery & Development, Others), By End-Use, and By Region Forecast to 2030

Duchenne Muscular Dystrophy Market, By Treatment Type (Corticosteroid therapy, Exon-Skipping Therapy, Mutation Suppression, Others), By End-Use (Hospitals & Clinics, Home-Care, Others), and By Region Forecast to 2030

Obstetrics and Gynecology Drugs Market, By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), By Application (Contraception, Gynecology Infections, and Female Infertility) By Distribution Channel, and By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-disposable-syringes-market
Trending Titles Rotator Cuff Injury Treatment Market | Soft Tissue Repair Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.